Skip to main content

High Throughput Bioprinting of Tumour Models for Drug Development and Oncology Research

Project description

Tumour bioprinting: the future of drug discovery

Call for proposal

H2020-SMEInst-2018-2020-2
See other projects for this call

Funding Scheme

SME-2 - SME instrument phase 2

Coordinator

CELLINK AB
Address
Arvid Wallgrens Backe 20
413 46 Goteborg
Sweden
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 2 450 327,25